As alt protein development and investment explodes around the world, there are concerns that current standards and practices for alt protein production, as well as national and international regulations, fall far behind innovation and consumer demand.
World’s First Plant-Based Covid Vaccine “Covifenz” Approved by Canada
Becoming the first country to approve the plant-based Covid-19 vaccine Covifenz, Canada sets the first milestone for a cost-effective approach to vaccine development. Canada-based biopharma company Medicago, which is part-funded by Philip Morris International (PMI), announced the development of a plant-based Covid-19 vaccine in 2020. Following the news of positive Phase 3 results in December 2021, Canada has approved the world’s first plant-based Covid-19 vaccine, which could be a guiding step in optimising vaccine technology. Leader in plant-based vaccines Operating under the slogan “Health is in our nature”, Medicago describes itself as a pioneer and leader in the development of plant-based vaccines. The vaccine development process uses living plants that are used as bioreactors to produce non-infectious particles mimicking the covid virus. Just as …
